Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 43

Cited In for PubMed (Select 10068383)

1.

Adolescent endogenous sex hormones and breast density in early adulthood.

Jung S, Egleston BL, Chandler DW, Van Horn L, Hylton NM, Klifa CC, Lasser NL, LeBlanc ES, Paris K, Shepherd JA, Snetselaar LG, Stanczyk FZ, Stevens VJ, Dorgan JF.

Breast Cancer Res. 2015 Jun 4;17(1):77. doi: 10.1186/s13058-015-0581-4.

2.

A systematic review of non-hormonal treatments of vasomotor symptoms in climacteric and cancer patients.

Drewe J, Bucher KA, Zahner C.

Springerplus. 2015 Feb 10;4:65. doi: 10.1186/s40064-015-0808-y. eCollection 2015.

3.

Hormone metabolism pathway genes and mammographic density change after quitting estrogen and progestin combined hormone therapy in the California Teachers Study.

Lee E, Luo J, Su YC, Lewinger JP, Schumacher FR, Van Den Berg D, Wu AH, Bernstein L, Ursin G.

Breast Cancer Res. 2014 Dec 11;16(6):477. doi: 10.1186/s13058-014-0477-8.

4.

Tracking progesterone receptor-mediated actions in breast cancer.

Knutson TP, Lange CA.

Pharmacol Ther. 2014 Apr;142(1):114-25. doi: 10.1016/j.pharmthera.2013.11.010. Epub 2013 Nov 26. Review.

5.

Viruses and breast cancer.

Lawson JS, Heng B.

Cancers (Basel). 2010 Apr 30;2(2):752-72. doi: 10.3390/cancers2020752.

6.

Mammographic parenchymal patterns as an imaging marker of endogenous hormonal exposure: a preliminary study in a high-risk population.

Daye D, Keller B, Conant EF, Chen J, Schnall MD, Maidment AD, Kontos D.

Acad Radiol. 2013 May;20(5):635-46. doi: 10.1016/j.acra.2012.12.016.

7.

Mammographic breast density response to aromatase inhibition.

Vachon CM, Suman VJ, Brandt KR, Kosel ML, Buzdar AU, Olson JE, Wu FF, Flickinger LM, Ursin G, Elliott CR, Shepherd L, Weinshilboum RM, Goss PE, Ingle JN.

Clin Cancer Res. 2013 Apr 15;19(8):2144-53. doi: 10.1158/1078-0432.CCR-12-2789. Epub 2013 Mar 6.

8.

Breast density measurements with ultrasound tomography: a comparison with film and digital mammography.

Duric N, Boyd N, Littrup P, Sak M, Myc L, Li C, West E, Minkin S, Martin L, Yaffe M, Schmidt S, Faiz M, Shen J, Melnichouk O, Li Q, Albrecht T.

Med Phys. 2013 Jan;40(1):013501. doi: 10.1118/1.4772057.

9.

Progestogens used in postmenopausal hormone therapy: differences in their pharmacological properties, intracellular actions, and clinical effects.

Stanczyk FZ, Hapgood JP, Winer S, Mishell DR Jr.

Endocr Rev. 2013 Apr;34(2):171-208. doi: 10.1210/er.2012-1008. Epub 2012 Dec 13. Review.

10.

Common breast cancer susceptibility variants in LSP1 and RAD51L1 are associated with mammographic density measures that predict breast cancer risk.

Vachon CM, Scott CG, Fasching PA, Hall P, Tamimi RM, Li J, Stone J, Apicella C, Odefrey F, Gierach GL, Jud SM, Heusinger K, Beckmann MW, Pollan M, Fernández-Navarro P, Gonzalez-Neira A, Benitez J, van Gils CH, Lokate M, Onland-Moret NC, Peeters PH, Brown J, Leyland J, Varghese JS, Easton DF, Thompson DJ, Luben RN, Warren RM, Wareham NJ, Loos RJ, Khaw KT, Ursin G, Lee E, Gayther SA, Ramus SJ, Eeles RA, Leach MO, Kwan-Lim G, Couch FJ, Giles GG, Baglietto L, Krishnan K, Southey MC, Le Marchand L, Kolonel LN, Woolcott C, Maskarinec G, Haiman CA, Walker K, Johnson N, McCormack VA, Biong M, Alnaes GI, Gram IT, Kristensen VN, Børresen-Dale AL, Lindström S, Hankinson SE, Hunter DJ, Andrulis IL, Knight JA, Boyd NF, Figuero JD, Lissowska J, Wesolowska E, Peplonska B, Bukowska A, Reszka E, Liu J, Eriksson L, Czene K, Audley T, Wu AH, Pankratz VS, Hopper JL, dos-Santos-Silva I.

Cancer Epidemiol Biomarkers Prev. 2012 Jul;21(7):1156-66. doi: 10.1158/1055-9965.EPI-12-0066. Epub 2012 Mar 27.

11.

No evidence for association of inherited variation in genes involved in mitosis and percent mammographic density.

Vachon CM, Li J, Scott CG, Hall P, Czene K, Wang X, Liu J, Fredericksen ZS, Rider DN, Wu FF, Olson JE, Cunningham JM, Stevens KN, Sellers TA, Pankratz SV, Couch FJ.

Breast Cancer Res. 2012 Jan 7;14(1):R7.

12.

Changes in breast density and circulating estrogens in postmenopausal women receiving adjuvant anastrozole.

Prowell TM, Blackford AL, Byrne C, Khouri NF, Dowsett M, Folkerd E, Tarpinian KS, Powers PP, Wright LA, Donehower MG, Jeter SC, Armstrong DK, Emens LA, Fetting JH, Wolff AC, Garrett-Mayer E, Skaar TC, Davidson NE, Stearns V.

Cancer Prev Res (Phila). 2011 Dec;4(12):1993-2001. doi: 10.1158/1940-6207.CAPR-11-0154. Epub 2011 Sep 1.

13.

High-density lipoprotein cholesterol, obesity, and mammographic density in Korean women: the Healthy Twin study.

Sung J, Song YM, Stone J, Lee K, Kim SY.

J Epidemiol. 2011;21(1):52-60. Epub 2010 Nov 6.

14.

Breast cancer risk by breast density, menopause, and postmenopausal hormone therapy use.

Kerlikowske K, Cook AJ, Buist DS, Cummings SR, Vachon C, Vacek P, Miglioretti DL.

J Clin Oncol. 2010 Aug 20;28(24):3830-7. doi: 10.1200/JCO.2009.26.4770. Epub 2010 Jul 19.

15.

Breast tissue composition and susceptibility to breast cancer.

Boyd NF, Martin LJ, Bronskill M, Yaffe MJ, Duric N, Minkin S.

J Natl Cancer Inst. 2010 Aug 18;102(16):1224-37. doi: 10.1093/jnci/djq239. Epub 2010 Jul 8. Review.

16.

Updated clinical recommendations for the use of tibolone in Asian women.

Huang KE, Baber R; Asia Pacific Tibolone Consensus Group.

Climacteric. 2010 Aug;13(4):317-27. doi: 10.3109/13697131003681458. Review.

17.

Sex steroids, growth factors and mammographic density: a cross-sectional study of UK postmenopausal Caucasian and Afro-Caribbean women.

McCormack VA, Dowsett M, Folkerd E, Johnson N, Palles C, Coupland B, Holly JM, Vinnicombe SJ, Perry NM, dos Santos Silva I.

Breast Cancer Res. 2009;11(3):R38. doi: 10.1186/bcr2325. Epub 2009 Jun 22.

18.

Short-term (1-2 mo) hormone therapy cessation before mammography.

Reed SD, Buist DS, Anderson ML, Bowles EJ, Fitzgibbons D, Seger D, Newton KM.

Menopause. 2009 Nov-Dec;16(6):1125-31. doi: 10.1097/gme.0b013e3181a5ce60.

19.

Longitudinal association of anthropometry with mammographic breast density in the Study of Women's Health Across the Nation.

Reeves KW, Stone RA, Modugno F, Ness RB, Vogel VG, Weissfeld JL, Habel LA, Sternfeld B, Cauley JA.

Int J Cancer. 2009 Mar 1;124(5):1169-77. doi: 10.1002/ijc.23996.

20.

Estrogen plus progestin and risk of benign proliferative breast disease.

Rohan TE, Negassa A, Chlebowski RT, Lasser NL, McTiernan A, Schenken RS, Ginsberg M, Wassertheil-Smoller S, Page DL.

Cancer Epidemiol Biomarkers Prev. 2008 Sep;17(9):2337-43. doi: 10.1158/1055-9965.EPI-08-0380. Epub 2008 Aug 25.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk